60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer

February 8, 2024

https://www.globenewswire.com/news-release/2024/02/08/2825942/0/en/60-Degrees-Pharmaceuticals-Appoints-Kristen-Landon-as-Chief-Commercial-Officer.html

WASHINGTON, Feb. 08, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today it has appointed Kristen Landon to the newly created role of Chief Commercial Officer, effective immediately. Ms. Landon is an accomplished commercial leader with over 26 years’ experience launching, building, and transforming commercial teams and brands in the pharmaceutical industry.

Read more at globenewswire.com

Related news for (SXTPW)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.